Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at William Blair in a research report issued on Wednesday, RTT News reports. Several other research firms also recently weighed in on ANRO. Robert W. Baird started coverage on shares of Alto Neuroscience in a research report on Tuesday, […]
Alto Neuroscience, Inc. today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York. Amit Etkin, M.D., Ph.D.,.
CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
ANRO Stock Earnings: Alto Neuroscience Misses EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.